BioCryst appoints Machelle Sanders (NC Commerce Sec., ex-Biogen) to board

BIOCRYST PHARMACEUTICALS INC

Appointed Machelle Sanders to board of directors effective Feb 8, 2022.
Board size increased from 11 to 12; she will serve on Science Committee.
Sanders is NC Secretary of Commerce and former Biogen operations exec with 30+ years pharma experience.
She receives automatic grant of 26,667 stock options upon joining and annual 40,000 options.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Machelle Sanders

Director

BCRX · BIOCRYST PHARMACEUTICALS INC

Effective: 2022-02-08
Filed: February 8, 2022, 6:59 PM ET

On February 4, 2022, the Board of Directors (the “Board”) of BioCryst Pharmaceuticals, Inc. (the “Company”) voted to increase the size of the Board from 11 directors to 12 directors and elected Machelle Sanders to fill the vacancy created by the enlargement of the Board, effective February 8, 2022 (the “Effective Date”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Machelle Sanders was elected as Director at BIOCRYST PHARMACEUTICALS INC.

Action: elected
Role: Director

Exact text from the filing

On February 4, 2022, the Board of Directors (the “Board”) of BioCryst Pharmaceuticals, Inc. (the “Company”) voted to increase the size of the Board from 11 directors to 12 directors and elected Machelle Sanders to fill the vacancy created by the enlargement of the Board, effective February 8, 2022 (the “Effective Date”).

View on SEC.gov

BIOCRYST PHARMACEUTICALS INC filing history →

Source: SEC EDGAR

accession 0001171843-22-000840

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.